Free Trial
OTCMKTS:EMMA

Emmaus Life Sciences (EMMA) Stock Price, News & Analysis

Emmaus Life Sciences logo
$0.01 +0.00 (+2.94%)
As of 08/7/2025 01:36 PM Eastern

About Emmaus Life Sciences Stock (OTCMKTS:EMMA)

Key Stats

Today's Range
$0.0140
$0.0140
50-Day Range
$0.0130
$0.0199
52-Week Range
$0.00
$0.05
Volume
28,025 shs
Average Volume
7,344 shs
Market Capitalization
$894.18 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EMMA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

EMMA Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Emmaus Life Sciences Inc
See More Headlines

EMMA Stock Analysis - Frequently Asked Questions

Emmaus Life Sciences' stock was trading at $0.0085 at the beginning of the year. Since then, EMMA shares have increased by 64.7% and is now trading at $0.0140.

Emmaus Life Sciences, Inc. (OTCMKTS:EMMA) released its quarterly earnings data on Thursday, May, 15th. The company reported ($0.04) earnings per share for the quarter.

Shares of EMMA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Emmaus Life Sciences investors own include Humanigen (HGEN), Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Acasti Pharma (ACST), Actinium Pharmaceuticals (ATNM) and Entasis Therapeutics (ETTX).

Company Calendar

Last Earnings
5/15/2025
Today
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:EMMA
CIK
822370
Employees
60
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.45 million
Net Margins
-26.79%
Pretax Margin
-26.55%
Return on Equity
N/A
Return on Assets
-17.85%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.09
Quick Ratio
0.06

Sales & Book Value

Annual Sales
$16.65 million
Price / Sales
0.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.88) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
63,870,000
Free Float
41,513,000
Market Cap
$894.18 thousand
Optionable
Not Optionable
Beta
8.03

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:EMMA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners